ROL vs TERN · P/E 41, rev $3.39B vs $6.12B cap
Rollins Inc (ROL) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the ROL and TERN stock pages for the full models.
Not investment advice.